Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 2, 2025

December 2, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201

GlobeNewswire

December 2, 2025

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging

GlobeNewswire

December 2, 2025

PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy

GlobeNewswire

December 2, 2025

BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

GlobeNewswire

December 2, 2025

Aeroflow Health Celebrates Giving Tuesday Through Donations to Western North Carolina Organizations

GlobeNewswire

December 2, 2025

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer

GlobeNewswire

December 2, 2025

Orbus Therapeutics Announces Publication of Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Improvements in Rare Brain Tumor in Journal of Clinical Oncology (JCO)

GlobeNewswire

December 2, 2025

Citizen Health Joins Forces with UCB to Accelerate Drug Development across Epilepsy and Rare Diseases

GlobeNewswire

December 2, 2025

Season Health and Albertsons Companies Launch Community Supports Service in California

GlobeNewswire

December 2, 2025

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors

GlobeNewswire

December 2, 2025

YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection

GlobeNewswire

December 2, 2025

Reema Health Tackles Medicaid Challenges with $19M Series B from LRVHealth and Optum Ventures

GlobeNewswire

December 2, 2025

Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG

GlobeNewswire

December 2, 2025

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

GlobeNewswire

December 2, 2025

PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

GlobeNewswire

December 2, 2025

PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)

GlobeNewswire

December 2, 2025

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

GlobeNewswire

December 2, 2025

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

GlobeNewswire

December 2, 2025

CORRECTION: Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery

GlobeNewswire

December 2, 2025

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

GlobeNewswire